ResultsIQ › Latest results › Natural Capsules Limited
Natural Capsules Limited Q2 FY27 results deck summary
NSE: NATCAPSUQ · BSE: 524654
Results deck of 15 Nov 2026, summarised by AI from the filing.
Q2FY27 revenue ₹51.15 cr and EBITDA ₹3.01 cr as converted gelatine lines added volumes; EBITDA expected to stay in the current range.
Key takeaways
- Revenue Q2FY27 consolidated revenue from operations was ₹51.15 cr, up 5% Q-o-Q and 12% Y-o-Y.
- EBITDA outlook EBITDA is expected to remain in the current range over the coming quarters, with input costs possibly rising.
- Line conversion Idle HPMC lines were converted to gelatine, adding volumes; the second HPMC line is now being converted.
- Volume driver Gelatine volumes from the converted lines drove growth, with the prior quarter's around 3% realisation gain holding.
- API approvals API revenue build depends on WHO GMP certification and COPP filings, expected complete by March 2027.
Natural Capsules Limited Q2 FY27 results
As filed: Revenue ₹51.2 cr (+11% year on year), EBITDA ₹3.0 cr, PAT −₹4.2 cr, EBITDA margin 5.9% (+808 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹48.7 cr (+8% year on year), EBITDA ₹1.1 cr (+12% year on year), PAT −₹5.7 cr, EBITDA margin 2.3% (+8 bps). Score 45 of 100, In line with trend. EBITDA margin was flat year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 17% from last quarter. Share price after the results: +19.1% in 30 days (Nifty 500: −3.4%).
- Q4 FY26: Revenue ₹58.5 cr (+30% year on year), EBITDA ₹1.3 cr (−73% year on year), PAT −₹5.0 cr (−300% year on year), EBITDA margin 2.3% (−884 bps). Score 20 of 100, Below trend. EBITDA margin fell 884 bps year on year. Consolidated profit -598% but standalone +84%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −6.5% in 29 days (Nifty 500: +0.6%).
- Q3 FY26: Revenue ₹34.2 cr, EBITDA ₹1.9 cr, PAT ₹0.4 cr, EBITDA margin 5.5%. Not scored. No result for the same quarter last year. Share price after the results: −10.5% in 28 days (Nifty 500: −8.2%).
- Q2 FY26: Revenue ₹45.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.1%. Not scored. No result for the same quarter last year. Share price after the results: −11.6% in 29 days (Nifty 500: −0.4%).
- Q1 FY26: Revenue ₹44.0 cr, EBITDA ₹4.0 cr, PAT ₹3.0 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: 0.0%).
- Q4 FY25: Revenue ₹44.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.4%. Not scored. No result for the same quarter last year. Share price after the results: −2.2% in 29 days (Nifty 500: +3.3%).
Past price moves after results do not indicate future moves. Not a recommendation.
Natural Capsules Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (15 Nov 2026)
- Q1 FY27: Results deck (13 Aug 2026), Results press release (13 Aug 2026)
- Q4 FY26: Earnings call (2 Jun 2026), Results deck (28 May 2026)
- Q3 FY26: Results deck (13 Feb 2026)
- Q2 FY26: Earnings call (17 Nov 2025), Results deck (14 Nov 2025)
- Q1 FY26: Results deck (5 Aug 2025)
- Q4 FY25: Earnings call (4 Jun 2025), Earnings call (4 Jun 2025), Results deck (31 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.